To compare the doses calculated by the Acuros XB (AXB) algorithm and analytical anisotropic algorithm (AAA) with experimentally measured data adjacent to and within heterogeneous medium using intensity modulated radiation therapy (IMRT) and RapidArc R (RA) volumetric arc therapy plans for nasopharygeal carcinoma (NPC). Methods: Two-dimensional dose distribution immediately adjacent to both air and bone inserts of a rectangular tissue equivalent phantom irradiated using IMRT and RA plans for NPC cases were measured with GafChromic R EBT3 films. Doses near and within the nasopharygeal (NP) region of an anthropomorphic phantom containing heterogeneous medium were also measured with thermoluminescent dosimeters (TLD) and EBT3 films. The measured data were then compared with the data calculated by AAA and AXB. For AXB, dose calculations were performed using both doseto-medium (AXB_D m ) and dose-to-water (AXB_D w ) options. Furthermore, target dose differences between AAA and AXB were analyzed for the corresponding real patients. The comparison of real patient plans was performed by stratifying the targets into components of different densities, including tissue, bone, and air. Results: For the verification of planar dose distribution adjacent to air and bone using the rectangular phantom, the percentages of pixels that passed the gamma analysis with the ± 3%/3mm criteria were 98.7%, 99.5%, and 97.7% on the axial plane for AAA, AXB_D m , and AXB_D w , respectively, averaged over all IMRT and RA plans, while they were 97.6%, 98.2%, and 97.7%, respectively, on the coronal plane. For the verification of planar dose distribution within the NP region of the anthropomorphic phantom, the percentages of pixels that passed the gamma analysis with the ± 3%/3mm criteria were 95.1%, 91.3%, and 99.0% for AAA, AXB_D m , and AXB_D w , respectively, averaged over all IMRT and RA plans. Within the NP region where air and bone were present, the film measurements represented the dose close to unit density water in a heterogeneous medium, produced the best agreement with the AXB_D w . For the verification of point doses within the target using TLD in the anthropomorphic phantom, the absolute percentage deviations between the calculated and measured data when averaged over all IMRT and RA plans were 1.8%, 1.7%, and 1.8% for AAA, AXB_D m and AXB_D w , respectively. From all the verification results, no significant difference was found between the IMRT and RA plans. The target dose analysis of the real patient plans showed that the discrepancies in mean doses to the PTV component in tissue among the three dose calculation options were within 2%, but up to about 4% in the bone content, with AXB_D m giving the lowest values and AXB_D w giving the highest values. Conclusions: In general, the verification measurements demonstrated that both algorithms produced acceptable accuracy when compared to the measured data. GafChromic R film results indicated that AXB produced slightly better accuracy compared to AAA for dose calculation adjacent to and within the heterogeneous media. Users should be aware of the differences in calculated target doses between options AXB_D m and AXB_D w , especially in bone, for IMRT and RA in NPC cases.
I. INTRODUCTION
Intensity modulated treatment techniques such as intensitymodulated radiotherapy (IMRT) and volumetric modulatedarc therapy (VMAT) are commonly used for the treatment of nasopharygeal carcinoma (NPC) due to the possibility of achieving better target coverage with lower doses to organsat-risk (OAR) compared to three-dimensional conformal radiotherapy (3DCRT). [1] [2] [3] [4] [5] The capability of producing highly conformal plans to patients should be accomplished with accurate dose calculation, especially when strong variation of densities in small volumes exists. A deterministic dose algorithm, the Acuros XB advanced dose calculation algorithm (AXB) has been implemented in the Eclipse treatment planning system (Varian Medical Systems, Palo Alto, CA) since 2010. It explicitly solves the linear Boltzmann transport equation (BTE) with numeric methods. The BTE is the governing equation that describes the macroscopic behavior of radiation particles as they travel through and interact with matter. Similar to the traditional Monte Carlo method, it allows for accurate modeling of dose deposition in heterogeneous media.
Several investigations have been performed to compare the dose calculation accuracy of the newly released AXB against Monte Carlo simulations and commonly used superpositionconvolution algorithms such as analytical anisotropic algorithm (AAA) and collapsed-cone convolution (CCC) method in homogeneous water and heterogeneous multilayer slab phantoms using single fields. [6] [7] [8] [9] [10] The media involved in the previous studies included tissue, normal lung, lowdensity lung, air, and bone. In general, the results indicated good agreement between AXB and Monte Carlo calculations, and AXB was considerably more accurate than superposition-convolution algorithms. Vassiliev et al. 6 assessed the performance of AXB from a pair of tangential fields in an anthropomorphic phantom for a breast case and found excellent agreement between AXB and Monte Carlo simulations.
Relatively few experimental verifications with clinical setup fields were found. Han et al. 11 have reported verification results of AXB for IMRT and VMAT using the Radiological Physics Center head and neck (RPC H&N) phantom. Predicted dose distributions by AAA and AXB with both doseto-medium (AXB_D m ) as well as dose-to-water (AXB_D w ) options were compared to doses measured using thermoluminescent dosimeters (TLDs) and GafChromic R EBT2 film. They observed that AXB_D m produced slightly better agreement with measurement results than AXB_D w and AAA. The RPC H&N phantom was made primarily of water-equivalent materials. Only very small air gaps existed near the TLD and film insert and their effects to the dose calculation were negligible. Thus, the effects from heterogeneities could not be fully investigated. Our previous study, which compared the performance of AXB and AAA using TLD measurement at and near air/tissue interfaces in an anthropomorphic phantom using intensity modulated stereotactic set-up fields found better agreement between AXB_D m and measurement compared to AAA. 12 However, the dose variation effect due to electronic disequilibrium for stereotactic fields was not the same as that for IMRT and VMAT fields in primary treatments due to the differences in field segment sizes, the target volumes being irradiated, the complexity of beam modulation, and beam directions. The main aim of this study was to perform verification of AXB_D m , AXB_D w and AAA dose calculations adjacent to and within heterogeneous medium with both air and bone for IMRT and RapidArc (RA) plans in NPC. The accuracy of the two-dimensional (2D) dose distribution adjacent to both air and bone inserts of a simple geometric phantom was validated with absolute dose gamma analysis using the newly released GafChromic R EBT3 film. The planar dose distribution near and within the nasopharygeal (NP) region of an anthropomorphic phantom containing heterogeneous medium was also measured using the EBT3 film. Besides, the accuracy of point doses near and adjacent to air and bone was verified in the anthropomorphic phantom using TLDs. This phantom was modified by the authors to accommodate TLD chips adjacent to and near air or bony structures in the head and neck region.
To further understand the differences in the calculated dose distributions between AAA and AXB, as well as between dose-to-medium and dose-to-water options of the AXB in materials of different densities, the target dose differences among AAA, AXB_D m , and AXB_D w were analyzed for the corresponding real patients. The comparison of real patient plans was performed by stratifying the targets into components of different densities, including tissue, bone, and air. The mean doses to the planning target volumes (PTV) divided into components of bone, air, tissue (the remaining tissue after excluding air and bone), tissue that was 3 mm adjacent to bone and tissue that was 3 mm adjacent to air for the IMRT and RA plans predicted by AAA, AXB_D m , and AXB_D w were calculated and compared. This might also help determine the correlation between the clinical planning results and the verification results.
II. MATERIALS AND METHODS

II.A. Phantoms for experimental verification
The head and neck cube of the commercially available Scanditronix Wellhofer I'mRT RW3 phantom (IBA Dosimetry, Uppsala, Sweden) containing air cavity and bone insert was used for verification of 2D distribution adjacent to heterogeneous medium. The dimension of the head and neck cube was 18 × 18 × 18 cm, in which the volume for accommodating phantom slabs was 16 × 16 × 16 cm, with 1 m edge on each side. An air cavity of 4 × 4 × 16 cm and a cylindrical bone insert of 16 cm length and 0.8 cm diameter with a physical density of 1.64 g/cm 3 were used as shown in Fig. 1 . Figure 1(a) shows the coronal view of the phantom, with the arrow indicating where the film was inserted adjacent to the heterogeneous media. Figure 1(b) shows the actual geometrical set-up of the cube relative to the radiation field when the film was placed on the axial plane. In order to take into account the Hounsfield unit (HU) of the film material in the CT scan during automatic material assignment for AXB dose calculation and minimize the partial volume effect on the CT image, an extra 2 mm thick of film material (created using discarded GafChromic films) was placed adjacent to the film for actual measurement as shown in Fig. 1(a) . Each film was cut to 16 × 9 cm and placed at the center of the axial plane. Perspex material of 2 mm thickness was precisely cut to fill up the rest of the spaces that was not occupied by films. In addition, to repeat similar measurements of planar dose distribution on the coronal plane, the cube was rotated by 90
• as shown in Fig. 1(c) . The film was placed on the center of the coronal plane immediately below the air cavity and bone inserts.
The head and shoulder region of an anthropomorphic phantom (the RANDO phantom, The Phantom Laboratory, Salem, NY) as shown in Fig. 2(a) was used for verification of point doses by TLD measurements and planar dose distributions near the NP region by film measurements. The phantom included bone, lung, and soft tissue compositions formulated for accurate simulation for therapy energies. The whole phantom was divided into 26 sections, each with 25 mm thickness, and only the first 11 phantom sections from the top of the head down to the shoulder region were used for the current investigation. For measurement of planar dose distributions, one film at a time was sandwiched between two of the phantom sections. The position of measurement was chosen to be near the NP region within tissue, bone, and air cavity. The film was cut carefully following the contour of the chosen phantom section. The thickness of the film was about 0.2 mm, which was much smaller than the CT scan slice. Direct CT simulation of the thin film within the NP region was not performed. Therefore, the film should only represent doses close to water density in heterogeneous medium. Each section of the phantom consisted of two registration pins that held phantom sections together in proper alignment. In order to anchor the film firmly and reproducibly between the phantom sections, two 6 mm diameter circular holes that precisely matched the positions and size of the registration pins to within 0.1 mm were cut from the films, as shown in Fig. 2(b) . Since the regions at and near the registration pins would produce inaccurate results for the gamma analysis, only the region anterior to the pins where most of the air and bone were present was included in the region of interest (ROI). For TLD measurement, only a few TLD recesses of the original phantom could be found near bone/tissue interfaces and almost none near air/tissue interface. The phantom was therefore modified by creating some TLD recesses near Fig. 2(c) . Besides, six TLD chips were placed near the brain stem outside the target volume to represent verification of doses in OAR, three of which were shown in Fig. 2(d) . Table I summarizes the distribution of the TLD positions in the phantom.
II.B. Treatment planning, dose calculation, and delivery
The CT scans of both the head and neck cube and the anthropomorphic phantom were performed with a GE LightSpeed RT 16-multislice CT simulator (GE Healthcare, Waukesha, WI). Although the slice thickness for the NPC planning of our routine clinical cases was 2.5 mm, a thinner slice thickness of 1.25 mm was used for the verification phantom scan for better visualization and sampling of the HU values of film and TLD chips.
Three patients with NPC who were previously treated with RA plans were replanned with sliding window IMRT. All plans were generated using 6 MV beam and modulated with 120 multileaf collimator (MLC) from a linear accelerator (Clinac 23EX, Varian Medical Systems). They were created with the Eclipse version 10.0 (Varian Medical Systems, Inc., Palo Alto). IMRT plans were created using nine fields that were evenly distributed in coplanar beam directions. The RA plans were created using two complete arcs, each with 358
• arc length plus one partial arc (from gantry angle of 240
• to 120
• in the clockwise direction). The couch angles of all arcs were 0
• . Nonzero collimator angles were used for all RA plans to reduce the tongue and groove effect. Three planning target volumes were defined for each patient, with 7000 cGy prescribed to PTV GTV (PTV including the gross target volume), 6000 cGy to PTV H_CTV (PTV including the high risk clinical target volume), and 5400 cGy to PTV L_CTV (PTV including the low risk target volume). Different dose levels to PTVs were achieved using simultaneous integrated boost technique (SIB). The optimization goal was to ensure at least 95% of the PTVs and 100% of the GTV to receive the prescribed dose, and no more than 5% of the PTV GTV would receive 107% of the prescribed dose while minimizing the doses to organs at risk (OARs). Optimization and dose calculation were originally performed based on AAA 10.0.28 with 2.5 mm grid resolution. The planning parameters of all six plans including beam angles, MLC leaf settings, jaws sizes, and monitor units (MU) were transferred to the CT images of the verification phantoms and then recalculated using AAA, AXB_D m , and AXB_D w of version 10.0.28.
AAA originally developed based on the superpositionconvolution method was implemented to replace the pencil beam model for more accurate dose calculation in heterogeneous media. It uses Monte Carlo derived kernels and provides a better modeling of the dose deposition in comparison to pencil beam model. Tissue inhomogeneities are taken into account by using radiologic scaling of the dose deposition functions in the beamlet direction and electron-density-based scaling of the scatter kernels in the lateral directions. Detailed description of the algorithm can be found in the papers by Ulmer et al. 13 and Fogliata et al. 14 Two options of dose reporting modes were available in AXB, dose-to-water, D w , and dose-to-medium, D m . Both options calculate dose considering the elemental composition of each material in which particles are transported. The only difference is in the postprocessing step, in which D w is obtained by rescaling D m using the stopping power ratio of water-tomedium. To account for material properties of the interested media, tissue segmentation is based on density ranges related to HU from the CT images, and for each tissue the specific chemical composition is considered based on ICRP 23 report. 15 Detailed description of the algorithm can be found in several previous publications. [6] [7] [8] [9] [10] The isocenter position in the anthropomorphic phantom was selected to be similar to that of the corresponding real patient. The isocenter position in the head and neck cube was chosen such that high dose regions covered the air and bone insert, as well as the film.
II.C. Film and TLD measurement
The GafChromic EBT3 films (Ashland, Specialty Ingredients, NJ) were used for the measurement of 2D dose distribution. There are some improvements in the design of the newly released EBT3 films when compared to EBT2 films. The 28 μm of active layer is sandwiched between layers of Matte Polyester substrate that negates Newton's rings. Its symmetric structure design allows the possibility of scanning the film from either side. All film analyses described in this study were performed with the Epson V700 (Epson, Suwa, Nagano) flat bed scanner using the response in red color channel. To minimize the warming up effects of the scanner lamp, at least seven successive scans for warm-up were performed at the beginning of each measurement series. The scanner was configured to scan with 150 dpi (0.17 mm/pixel). Several tests were performed regarding the performance of the film before they were used for the actual planar dose verifications. The reproducibility of the scanner was found by repeated scanning of the same film irradiated to 100 cGy for 20 times. The relative standard deviation (RSD) of scanned values was found to be 0.4%. The intrasheet uniformity was determined by cutting small pieces of 5 × 5 cm films at different positions from the same sheet exposed to 100 cGy. The variation of scanned values at different positions was within ± 0.5%. The homogeneity among several films (interfilm uniformity) of the same batch was found by exposing small pieces of films that were cut from three different sheets exposed to the same dose. The variation of scanned values among different films was found to be within ± 0.5%. For determination of the influence of the film orientation during scanning, four pieces of films exposed from 25 to 400 cGy were scanned in landscape, portrait directions and also on both sides. The averaged difference in the scanned values between portrait and landscape scan was 12%, while that between both sides was only 0.5%. The dose calibration curves were determined by exposing small pieces of films (5 × 5 cm) to seven different doses ranged from 25 to 250 cGy. The films for measuring all planar dose distribution of the head and neck cube were cut from the original sheets of the same batch. All films were scanned on the day following the irradiations. Each piece of film was scanned near the center of the scanner in the landscape orientation of the same side facing upwards. The data were analyzed using the Rochester Institute of Technology (RIT) software version 4.3 (Radiological Imaging Technology, Inc., Colorado Spring). The dose to optical density calibration curve was used to convert the measured planar film image to a dose image which was then compared to the IMRT plan or RA plan in the film plane. Gamma index analysis with the test criteria of 3% dose agreement within a distance to agreement (DTA) of 3 mm (3%/3 mm), and also 2% dose agreement within a DTA of 2 mm (2%/2 mm) were performed. A rectangular ROI for the film analysis using the head and neck cube was defined to include mainly the high dose region near the PTV together with the nearby dose falloff gradient, with a typical example shown in Fig. 3 . It mainly included regions adjacent to both air and bone inserts. A gamma value of larger than 1 would be assigned for points failing the gamma criterion within the ROI. The percentage of points with gamma >1 was assessed as a measure of disagreement between measurements and calculations. To reduce statistical uncertainty, the measurement for each plan was repeated three times. Three IMRT plans and three RA plans were validated. Planar dose distributions on both axial and coronal planes adjacent to air and bone inserts were measured. The confidence limit, CL, used in the TG 119 study to define the acceptability of the results was also estimated in this film study. 16 CL is defined as the sum of the absolute value of the average difference and the standard deviation of the differences multiplied by a factor of 1.96 (CL = |mean|+ 1.96 σ ). Almost exactly the same procedures were used for the film analysis in the anthropomorphic phantom. Planar dose distribution measurements were only performed on the axial plane, as the phantom did not allow the placement of film on the coronal plane. The ROI for gamma analysis was chosen to exclude points near the edge of the contour, and those at and posterior to the two registration pins. As a result, the ROI mainly included those high dose regions near the target volumes together with dose falloff near the brain stem.
Doses at 18 different reference points were measured by LiF TLD-100 (3 × 1 × 1 mm) for three IMRT plans and three RA plans in the head and shoulder region of the anthropomorphic phantom. All TLDs were annealed at 400
• C for 1 h and 100
• C for 2 h before irradiation. The whole set of TLDs were irradiated with a known dose of 100 cGy using 10 × 10 cm 6 MV x-ray beam before the actual measurement. To remove the short half-life peaks, the irradiated TLDs were preheated at 100
• C for 10 min. They were read by the Harshaw Model 5500 reader (Thermo Electron Corporation, Ohio). The precision of TLD measurement could be reduced to about 2% by assigning individual sensitivity value to each chip of one set. 17, 18 The whole set of TLD chips were irradiated using 6 MV beam to 100 cGy in solid water at a depth of 5 cm. From the calibration, each chip was assigned a sensitivity value which related its individual dose response to the mean dose response of the set. The sensitivity value was then taken as the running average of three calibrations. A recalibration of individual sensitivity of each chip of the whole set was performed after one month. Based on comparisons between repeated irradiations of the TLD chips in a constant setup to a known dose, the precision of TLD measurement was 2.3%. During the actual measurement, the phantom for each plan was repeated three times and the averaged values were taken to reduce statistical errors. The originally prescribed dose to the target volume was 7000 cGy in 35 fractions (200 cGy per fraction). In order to perform all the measurement within the linear dose response range of the TLD-100 chips, the prescribed dose was reduced to 90 cGy per fraction. All TLDs were put to the reference positions and CT scanned together with the phantom. All the TLD chips selected for dose verification were clearly seen from the CT images. All TLDs within the target were at positions of uniform doses. High dose gradient was avoided, so that the influence of set-up error on measured doses could be minimized during delivery. However, those TLDs for measuring the doses near OAR were at regions of relatively higher dose gradient. Each TLD chip was manually contoured in the planning CT images and the calculated mean dose of each was taken as the calculated doses.
II.D. PTV analysis for real patients
For the six real patient plans (three IMRT and three RA plans) described in Secs. II.B and II.C, the effect of heterogeneity on the dose calculations among AAA, AXB_D m , and AXB_D w was also further studied by analyzing the PTV doses. Since PTV GTV included the largest proportion of bone and air compared to the other PTVs with lower dose prescription, analysis was confined to PTV GTV in the current study. The air cavities and bony structures in PTV GTV were contoured separately as PTV GTV _air and PTV GTV_ bone, as shown in Figs. 4(a) and 4(b). The rest of the volumes other than bone and air were contoured as PTV GTV _tissue, as shown in Fig. 4(c) . Besides, the tissue that was 3 mm adjacent to air and bone, was contoured as separate organ, i.e., PTV GTV _adj air and PTV GTV _adj bone, respectively, as shown in Figs. 4(d) and 4(e). For the originally contoured PTV GTV and those corresponding stratified components, mean doses were calculated and compared. Table II summarizes the results of the gamma evaluations for the three clinical NPC cases using IMRT and RA plans on the axial plane using the head and neck cube. It can be seen that good agreements were found for the planar dose comparison with the 3%/3 mm criteria between measurements and all three calculation options. The percentage of pixels failing the 3%/3 mm criteria within the rectangular ROI averaged over all measurements and all plans was 1.3 ± 1.5%, 0.5 ± 0.5%, and 2.3 ± 2.3% for AAA, AXB_D m , and AXB_D w , respectively. The estimated CL values of both AAA and AXB were well within the action levels recommended by TG 119. When the restriction of gamma evaluation was raised to the criteria of 2%/2 mm, the percentage of pixels failing the gamma index increased to 7.4 ± 6.0%, 4.2 ± 3.5%, and 9.6 ± 9.1% for AAA, AXB_D m , and AXB_D w , respectively. Looking at the gamma evaluation with both 3%/3 mm and 2%/2 mm criteria for each individual plan, the planar dose distribution calculated by AXB_D m showed the best agreement with the measured dose distribution by films for all plans except the RA plan for case 3. However, for this case the passing rates among the three calculation options were close to each other. At least it could be concluded that the passing rates for AXB_D m for this plan was as good as the other two options.
III. RESULTS
III.A. Verification of planar dose with EBT3 films in head and neck cube
The absolute values of averaged percentage dose differences between the calculated and measured values within the ROI averaged over all measurements and all plans were within 3% for the three calculation options. It was 1.8 ± 1.5%, 1.2 ± 1.8%, and 2.2 ± 1.8% for AAA, AXB_D m , and AXB_D w , respectively. For most of the plans, the averaged doses predicted using AAA and AXB_D w were slightly higher than the measured doses. It was up to about 3% for AAA and 4% for AXB_D w . The average doses predicted using AXB_D m were lower than the measured values for some cases (the IMRT plans of cases 1 and 2, the RA plan of case 3), while higher than the measured values for the rest of the cases. It could also be observed that AXB_D m predicted lower average planar doses than the other two options.
Figures 5(a)-5(c) show the spatial distribution of the gamma analyses with 3%/3 mm criterion for one film irradiated using the IMRT plan of case 1. By comparing the figures, it can be seen that the area of dose differences between measured doses and calculated doses using AXB_D m was relatively smaller than that when the doses were calculated with AAA and AXB_D w . Table III summarizes the results of the gamma evaluations on the coronal plane using the head and neck cube. Good agreements were also found for the comparison using the 3%/3 mm criteria between measurements and all three calculation options. The percentage of pixels failing the 3%/3 mm criteria within the ROI averaged over all measurements and all plans was within 3% for all three calculation options. The estimated CL values were all well within the TG 119 recommended action levels, with a slightly higher passing rate observed for AXB_D m when compared to that of AAA and AXB_D w .
III.B. Verification of planar dose with EBT3 films in anthropomorphic phantom
Table IV summarizes the averaged results of the gamma evaluations for film measurement within the NP region of the head and shoulder anthropomorphic phantom. The percentage of pixels failing the 3%/3 mm criteria averaged for all plans was 4.9 ± 3.1%, 8.7 ± 3.6%, and 1.0 ± 0.6% for AAA, AXB_D m , and AXB_D w , respectively. When the restriction of gamma evaluation was raised to the criteria of 2%/2 mm, the percentage of pixels failing the gamma index increased to 18.0 ± 5.9%, 22.0 ± 5.6%, and 6.2 ± 3.0% for AAA, AXB_D m , and AXB_D w , respectively. Consistently better agreement can be found between measurements and AXB_D w than AAA and AXB_D m . The comparison results were similar between IMRT and RA plans. The estimated CL values of both AAA and AXB_D w were within the action levels recommended by TG 119. The relatively larger disagreement between AXB_D m and the measured data was mainly due to the fact that the measured doses by tissue equivalent film only represented doses close to unit water density within the heterogeneous medium.
III.C. Verification of point dose with TLD
The results of the anthropomorphic head and shoulder phantom verification measurement for the 12 points at/near heterogeneous interfaces within the target of IMRT plans and RA plans are shown in Tables V and VI, respectively. The average SD of all measurement points was 1.2%, with a range from 0.2% to 3.3%, showing reasonable consistency of the measurements. The dose variation of the algorithms came from the standard deviation of the predicted doses within the volume of each contoured TLD chip. Such variation was mostly within 1% inside the target. The absolute discrepancy [i.e., absolute value of (calculated dose − averaged measured dose)/averaged measured dose × 100%] between the measured and predicted values when averaged over all measurement points and all plans was 1.8 ± 1.2%, 1.7 ± 1.2%, and 1.8 ± 1.1% for AAA, AXB_D m , and AXB_D w , respectively. For IMRT plans, the average absolute discrepancy was 1.9 ± 1.2%, 1.7 ± 1.1%, and 1.8 ± 1.1% for AAA, AXB_D m , and AXB_D w , respectively. For RA plans, it was 1.7 ± 1.3%, 1.7 ± 1.2%, and 1.8 ± 1.2%, respectively. Tables VII and VIII show the verification results in OAR. For IMRT plans, the average absolute discrepancy was 1.9 ± 1.3%, 2.5 ± 1.1%, and 2.5 ± 0.8% for AAA, AXB_D m , and AXB_D w , respectively. For RA plans, it was 2.3 ± 0.7%, 1.9 ± 0.4%, and 2.6 ± 0.1%, respectively. Figure 6 summarizes the mean percentage discrepancy [i.e., (predicted dose − measured dose)/measured dose *100%] over all plans and all cases. The TLD results showed acceptable accuracy for both AAA and AXB at the selected points, and did not show any significant difference in the dose calculation accuracy among the three calculation options. Moreover, no significant difference could be observed between the results of IMRT and RA plans. Table IX summarizes the mean doses to PTV GTV and its different components in air, bone, tissue, the 3 mm tissue adjacent to bone, and the 3 mm tissue adjacent to air averaged separately over the three IMRT and the three RA plans used in Secs. III.A-III.C. Among the three options, AXB_D m predicted the lowest PTV doses while AXB_D w predicted the highest PTV doses. For IMRT plans, it can be observed that the mean dose to PTV GTV estimated by AXB_D m and AXB_D w compared to AAA was 1.1% lower and 0.6% higher, respectively. The mean doses to all stratified components except PTV GTV in air predicted by AXB_D m were lower than those predicted by AAA. The amount of dose reduction was highest in bone. It was 1.2% lower for PTV GTV _tissue, 2.4% lower for PTV GTV _bone, 0.7% lower in tissue adjacent to bone, and 0.5% lower in tissue adjacent to air. On the other hand, the mean doses to all stratified components predicted by AXB_D w were higher than those predicted by AAA. The amount of increase in the mean dose was highest in bone. It was 1.9% in bone and mostly within 1% for all the other stratified components. The differences in mean doses between AXB_D m and AXB_D w were mostly within 2% except for the component in bone, for which a difference of up to 4.3% was found. Very similar results were found for the RA plans. Figures 7(a)-7(d) show the differential dose volume histograms of the stratified PTV GTV structures calculated using the three different calculation options for the IMRT plan of case 1. They displayed the share of the total volumes in the interested structures receiving a certain dose as a function of equivalent dose intervals. From the spread of dose differences among the three options, it was observed that larger dose differences were found between AXB_D m and AXB_D w than those between AAA and AXB_D m for all components. Besides, larger differences in dose distribution among the three calculation options were found in bone than in tissue. The differences found in the tissue adjacent to bone and air were similar to the rest of the tissue in PTV GTV .
III.D. Stratified PTV doses for real patients
IV. DISCUSSION
Although previous investigations proved that AXB_D m predicted significantly more accurate doses in and near heterogeneous media from single fields compared to AAA, [6] [7] [8] [9] [10] the differences might not be as obvious for clinical IMRT and RA fields. For a single field with the presence of air cavity, AXB predicted lower in-field doses, and higher out-of-field doses near air/tissue interfaces compared to AAA due to the better modeling of lateral electronic disequilibrium effect. 12 When multiple field segments are used, the dose variation due to heterogeneity, especially due to low density media such as air from one single field segment would be compensated by adjacent field segments from the same field direction or other field segments coming from different directions.
The verification of the planar dose distribution adjacent to heterogeneous media by film using the head and neck cube reflected satisfactory results for all the three calculation options. The passing rates of the 3%/3mm criterion were higher than 94% on the axial plane and 92% on the coronal plane for all plans calculated by different calculation methods. Although the differences were small, AXB_D m showed slightly better agreement with measured dose distributions than the other two options on the axial plane. For the axial plane, the presence of air and bone adjacent to the film affected the doses mostly in terms of lateral electron transport and lateral scatter. This might be because AXB_D m produced better modeling of lateral dose transport in air compared to AAA, and more accurate calculation of lateral scatter and exit doses from the compact bone than both AAA and AXB_D w . The effect was slightly different and became more complicated when the dose distribution measured by film was on the coronal plane. Radiation fields coming from different directions affected the doses to the interested interface differently. For example, those anterior and anterior oblique fields passed through air and bone before reaching the interface, while those posterior and posterior oblique fields interacted with the interface before passing through the air and bone. The doses on the interface below air and bone could be affected by secondary build-up and build-down effect, forward and backward scatter, lateral scatter, and beam transmission, depending on the beam direction. This might explain why the comparison results on the coronal plane did not reflect consistently better agreement between AXB_D m and measured doses as on the axial plane. The verification of planar dose distribution using the head and neck cube was different from that using the anthropomorphic phantom. For the head and neck cube verification, the position of the interested slice was adjacent to bone and air, but was still situated in a tissue equivalent medium. During dose calculation, AXB_D m represented doses to the tissue equivalent film and AXB_D w represented doses to unit density water. Both should be close to each other. The main difference between the two calculation options would be the calculated scattered doses from the adjacent bone and air. On the other hand, for the film experiment performed using the anthropomorphic phantom, the slice of interest was situated directly within the heterogeneous medium of the NP region. Part of the film was sandwiched between bony structures. The presence of bone material within the NP region did make a difference between dose-to-water and dose-to-medium calculation. The bone was different from water in both density and atomic number. For example, a stopping power ratio of water to cortical bone of up to 1.1 could be used to convert doseto-medium to dose-to-water in the medium. Direct CT simulation of the thin film (0.2 mm) within the NP region was not possible, as it was not practical to perform CT scan of such a thin film with 1.25 mm slice thickness (the smallest slice thickness available for our CT scanner). Therefore, the dose distribution at the selected plane calculated by AXB_D m should only reflect the doses to bone, air, and tissue within the NP region. Since the EBT3 film itself was tissue-equivalent, its measurement actually represented doses in a medium close to water density in the selected plane. The EBT3 film measured doses should therefore be compared to those calculated by AXB_D w instead of AXB_D m . This issue was discussed by Wilcox and Daskalov 19 and Siebers et al. 20 using Monte Carlo simulations. AAA computed and reported the absorbed dose as if it were deposited in water, not in medium. The doses predicted by AAA should be directly compared to film. Based on the above argument, we conclude from our investigation Tables V-VIII for the selected points, the uncertainties listed for the algorithms were the dose variations within the contoured volumes of the TLD chips, which were mostly about 1% in the target and 2%-3% in OAR outside the target. As can be seen from the tables, although there were differences among the calculated doses by the three calculation options, they were mostly about 1%-2%. The precision of the TLD measurement was about 2%-3%. Therefore, the TLD measurement could not distinguish the accuracy difference among AAA, AXB_D m , and AXB_D w . However, from this experiment, the authors could at least ensure that the discrepancies between the measured values and predicted values were within acceptable limit for AAA and AXB at/near the heterogeneous interfaces. The amount of dose variation due to air cavity strongly depends on the field size. The effect of lateral electronic equilibrium increases as the field size decreases. In our previous study, verification by TLD using stereotactic IMRT fields for persistent NPC showed significant improvement in the dose accuracy using AXB. 12 For IMRT and RA fields of primary NPC, the sizes of field segments were larger than those for stereotactic radiotherapy boost due to the need of irradiating much larger target volumes. Besides, the materials passed by the irradiating fields are also different. For example, compared to persistent NPC, the target volume of primary NPC involved more bone content. Therefore, the amount of improvement of dose calculation accuracy demonstrated by AXB compared to that of AAA observed in the current study was less significant.
From the result of the PTV dose analysis in real patients, it was observed that the discrepancies in doses calculated in bone among the three calculated options were larger than those in air, adjacent tissue, and the other remaining tissues. It was within 2% in tissue adjacent to bone and air, and could be about 4% in bone. This matched with the verification results where significant difference in the dose calculation accuracy between AAA and AXB was not found. AAA computes the transport and dose deposition using radiological and density scaling. It computed and reported the absorbed dose as if it were deposited in water. Both options of AXB calculated dose considering the elemental composition of bony structures. Doses calculated using AXB_D w was generated by converting the doses calculated by AXB_D m with the stopping power ratio for water to the specific medium. The stopping power ratio of water to bone is about 1.03 for soft bone and 1.1 for cortical bone. As a result, AXB_D m computed a lower dose within bony structure than AXB_D w . Previous investigations showed that the doses calculated by AXB_D m in bone matched well with those predicted by Monte Carlo simulations. [8] [9] [10] It was also found that the doses calculated by AAA in bone were closer to AXB_D m than to AXB_D w . A previous study using Monte Carlo calculations proved that conventional photon dose calculation using water with relative electron densities produced dose distributions in bone were much closer to D m distributions than to D w distributions for high-energy (4-18 MV) photon beams. They therefore suggested to use D m in Monte Carlo photon algorithms for consistency with previous radiation therapy experience, and stated that their recommendations should be applicable to other deterministic dose algorithms or other model-based algorithms. 21 According to the recommendation of AAPM report 105, algorithms taking into account the elemental compositions of materials for dose calculations should provide both dose-to-medium and dose-towater options for users. 22 There are a few arguments for using the D w options: (1) Conventional dose algorithms compute and report the absorbed dose as if it were deposited in water. (2) Beam data are always measured in water for the commissioning of the treatment planning system. (3) Absorbed doseto-water based ionization chamber calibration protocols are used for treatment machines, and (4) tumor cells even when embedded in bone behave like water. Since these two options are available in AXB for the users to select, it is very important for them to be aware that using AXB_D w will calculate up to 4% more mean doses to the PTV in bone, and up to about 2% more mean doses to the tissues adjacent to bone compared to AXB_D m for IMRT and RA of NPC. Slightly higher doses to the nearby tissues predicted by AXB_D w might be due to the larger exit and scattered doses from bone. A previous study using Monte Carlo method also showed dose differences of up to 5.8% in target between D m and D w calculations for head and neck cases. 23 Our study using stratified components clearly showed that the dose differences in bone between D w and D m were larger than those in the other tissues. The observation from our results could also apply to the IMRT and RA of other head and neck cases.
V. CONCLUSION
The experimental validation study using the anthropomorphic phantom by TLD showed both AAA and AXB produced acceptable accuracy for dose calculation adjacent to heterogeneous media for IMRT and RA plans of NPC. The planar dose verifications using film showed that AXB produced slightly better or equivalent accuracy compared to AAA adjacent to and within the heterogeneous medium. Users using the AXB algorithm for improving dose calculation accuracy should be aware of the dose differences in target volumes between options of D m and D w . It should be noted that dose predicted by D w is usually higher than that predicted by the D m option, especially in bone and tissues adjacent to bone.
